GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (TSXV:CANB) » Definitions » Cash-to-Debt

CanadaBis Capital (TSXV:CANB) Cash-to-Debt : 0.13 (As of Oct. 2024)


View and export this data going back to 2017. Start your Free Trial

What is CanadaBis Capital Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. CanadaBis Capital's cash to debt ratio for the quarter that ended in Oct. 2024 was 0.13.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, CanadaBis Capital couldn't pay off its debt using the cash in hand for the quarter that ended in Oct. 2024.

The historical rank and industry rank for CanadaBis Capital's Cash-to-Debt or its related term are showing as below:

TSXV:CANB' s Cash-to-Debt Range Over the Past 10 Years
Min: 0   Med: 0.21   Max: No Debt
Current: 0.13

During the past 9 years, CanadaBis Capital's highest Cash to Debt Ratio was No Debt. The lowest was 0.00. And the median was 0.21.

TSXV:CANB's Cash-to-Debt is ranked worse than
81.69% of 1016 companies
in the Drug Manufacturers industry
Industry Median: 0.93 vs TSXV:CANB: 0.13

CanadaBis Capital Cash-to-Debt Historical Data

The historical data trend for CanadaBis Capital's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

CanadaBis Capital Cash-to-Debt Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only 0.03 0.10 0.02 0.44 0.26

CanadaBis Capital Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.36 0.21 0.26 0.13

Competitive Comparison of CanadaBis Capital's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanadaBis Capital's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's Cash-to-Debt falls into.



CanadaBis Capital Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

CanadaBis Capital's Cash to Debt Ratio for the fiscal year that ended in Jul. 2024 is calculated as:

CanadaBis Capital's Cash to Debt Ratio for the quarter that ended in Oct. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanadaBis Capital  (TSXV:CANB) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


CanadaBis Capital Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


CanadaBis Capital Business Description

Traded in Other Exchanges
Address
255C Clearview Drive, Red Deer County, Red Deer, AB, CAN, T4E 3B6
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extraction and tolling segment provide cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.
Executives
Garfield Richards Senior Officer
Shane Chana Director